Metabomed is a drug discovery company in the field of cancer metabolism with a proprietary target identification platform based on computational biology and metabolomics. Metabomed focuses on targets which are synthetically lethal for biomarker- defined tumors.

biopharmaceuticals
Private
Visit Website
Additional Portfolio Companies
Adicet Bio
ARTSaVIT
BioBlast Pharma
Cathworks
cCAM Biotherapeutics
CheckCap
Eloxx Pharmaceuticals
Enlivex Therapeutics
Entera Bio
Eyevensys
EyeYon
Hairstetics
Headsense
Keros Therapeutics
Kite Pharma
Leap Therapeutics
LogicBio Therapeutics
Metabomed
NovellusDX
Novus Therapeutics
Nutrinia
Ocon Medical
PACT Pharma
Pi Therapeutics
Protalix
Raziel Therapeutics
ReWalk
StimatixGI
Sweetch
TargEDys
UroGen
V-Wave
Zolex Therapeutics
July 12, 2015